%0 Journal Article
%T Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD
%A Katie Almond
%A Robert Allan
%J The Family Journal
%@ 1552-3950
%D 2019
%R 10.1177/1066480719852360
%X This article explores incorporating 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct in emotionally focused couples therapy (EFT) with clients in which at least one participant has endured a traumatic experience and reports symptoms of post-traumatic stress disorder (PTSD). Despite classification as a Schedule I drug on the Controlled Substances Act (CSA), in 2017 the U.S. Food and Drug Administration designated MDMA as a ˇ°breakthrough therapyˇ± in the treatment of PTSD and approved plans for a Phase 3 clinical trial sponsored by the Multidisciplinary Association for Psychedelic Studies. This article aims to integrate previous and current research involving the therapeutic use of MDMA-assisted psychotherapy into the treatment of PTSD with the systemic, evidence-based approach of EFT
%K 3
%K 4-methylenedioxymethamphetamine
%K MDMA
%K emotionally focused couples therapy
%K EFT
%K trauma
%K couples counseling
%K post-traumatic stress disorder
%K PSTD
%U https://journals.sagepub.com/doi/full/10.1177/1066480719852360